ARAV Aravive Inc

Price (delayed)

$5.20

Market cap

$102.23M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.93

Enterprise value

$47.78M

Sector: Healthcare
Industry: Biotechnology

Highlights

ARAV's gross profit is up by 20% YoY
The company's revenue rose by 20% YoY
The company's EPS fell by 23% YoY but it rose by 5% QoQ
The company's net income has shrunk by 68% YoY
The company's quick ratio has shrunk by 51% YoY and by 42% QoQ

Key stats

What are the main financial stats of ARAV
Market
Shares outstanding
19.66M
Market cap
$102.23M
Enterprise value
$47.78M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.74
Price to sales (P/S)
14.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.4
Earnings
Revenue
$5.69M
EBIT
-$30.54M
EBITDA
-$28.71M
Free cash flow
-$12.17M
Per share
EPS
-$1.93
Free cash flow per share
-$0.77
Book value per share
$2.99
Revenue per share
$0.36
TBVPS
$4.28
Balance sheet
Total assets
$67.71M
Total liabilities
$19.66M
Debt
$8.52M
Equity
$48.06M
Working capital
$52.23M
Liquidity
Debt to equity
0.18
Current ratio
6.52
Quick ratio
6.66
Net debt/EBITDA
1.9
Margins
EBITDA margin
-505.1%
Gross margin
100%
Net margin
-537.3%
Operating margin
-541.5%
Efficiency
Return on assets
-45%
Return on equity
-56.6%
Return on invested capital
-324.6%
Return on capital employed
-52.4%
Return on sales
-537.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ARAV stock price

How has the Aravive stock price performed over time
Intraday
0.39%
1 week
-2.62%
1 month
-43.72%
1 year
-54.43%
YTD
-7.8%
QTD
-21.09%

Financial performance

How have Aravive's revenue and profit performed over time
Revenue
$5.69M
Gross profit
$5.69M
Operating income
-$30.78M
Net income
-$30.54M
Gross margin
100%
Net margin
-537.3%
The company's net income has shrunk by 68% YoY
The operating income has declined by 41% year-on-year but it has grown by 3.5% since the previous quarter
The company's net margin fell by 40% YoY
ARAV's gross profit is up by 20% YoY

Growth

What is Aravive's growth rate over time

Valuation

What is Aravive stock price valuation
P/E
N/A
P/B
1.74
P/S
14.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.4
The company's EPS fell by 23% YoY but it rose by 5% QoQ
The company's equity fell by 30% YoY and by 2.7% QoQ
ARAV's P/B is 21% below its 5-year quarterly average of 2.2 and 14% below its last 4 quarters average of 2.0
The company's revenue rose by 20% YoY

Efficiency

How efficient is Aravive business performance
Aravive's ROA has plunged by 75% YoY and by 4.4% from the previous quarter
The ROE has shrunk by 74% YoY and by 9% QoQ
Aravive's return on invested capital has decreased by 41% QoQ
The company's return on sales fell by 40% YoY

Dividends

What is ARAV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ARAV.

Financial health

How did Aravive financials performed over time
ARAV's total liabilities has surged by 66% since the previous quarter and by 50% year-on-year
Aravive's current ratio has shrunk by 53% YoY and by 43% QoQ
The company's debt is 82% lower than its equity
The company's equity fell by 30% YoY and by 2.7% QoQ
Aravive's debt to equity has increased by 20% YoY and by 6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.